(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ADAPTIVE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ADAPTIVE

ST13

US500000087878532

Classe

42, 44

Pedido

87878532

Registro

6866517

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

52

Atualização mais recente

04/10/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42, 44

Data de depósito

16/04/2018

Data de registro

04/10/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

04/10/2022

Última transação

04/10/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

08/09/2009

Primeiro uso no comércio

08/09/2009

Código do desenho

4

Tipo de titular

03

Localização do titular

Seattle, WA

Examinador

CHADAB, SETH

Unidade examinadora

L40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

A. C. (pessoa física)

Representantes

Hoang-chi Truong Patent Law Works LLP

Classificação técnica

Classes Nice

Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expressioncancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; researchdevelopmentengineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapyoncologyhematologyauto-immune disordersinfectious diseases; medical and scientific research in the field of immunotherapy

Classe 44

Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual diseasethe analysisevaluationreporting of those test results to help healthcare professionals determine a patient's clinical diagnosisthe effectiveness of patient treatmentsto revise future treatments accordingly

Publicações

Histórico de despachos e eventos da marca no USPTO.

52 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

04/10/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

30/08/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

29/08/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/08/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/08/2022

EX1G

SOU EXTENSION 1 GRANTED

05/08/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/08/2022

EXT1

SOU EXTENSION 1 FILED

15/07/2022

IUAF

USE AMENDMENT FILED

15/07/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/07/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/07/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/07/2022

EEXT

SOU TEAS EXTENSION RECEIVED

15/07/2022

EISU

TEAS STATEMENT OF USE RECEIVED

15/07/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

18/01/2022

TMBN

TTAB RELEASE CASE TO TRADEMARKS

07/12/2021

OP.D

OPPOSITION DISMISSED NO. 999999

07/12/2021

TTBN

CASE ASSIGNED TO TTAB

10/12/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/12/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

18/08/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/07/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/07/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/07/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/07/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/07/2020

TMBN

TTAB RELEASE CASE TO TRADEMARKS

07/07/2020

OP.T

OPPOSITION TERMINATED NO. 999999

07/07/2020

OP.D

OPPOSITION DISMISSED NO. 999999

07/07/2020

PCDE

PETITION TO DIRECTOR DENIED

27/09/2019

APET

ASSIGNED TO PETITION STAFF

19/08/2019

APET

ASSIGNED TO PETITION STAFF

20/06/2019

APET

ASSIGNED TO PETITION STAFF

24/05/2019

TPDR

TEAS PETITION TO DIRECTOR RECEIVED

17/04/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/04/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/04/2019

OP.I

OPPOSITION INSTITUTED NO. 999999

19/11/2018

OPPF

OPPOSITION PAPERS RECEIVED AT TTAB

19/11/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

13/11/2018

PUBO

PUBLISHED FOR OPPOSITION

13/11/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/10/2018

ALIE

ASSIGNED TO LIE

05/10/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/09/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/09/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

17/09/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

17/09/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2018

GNRT

NON-FINAL ACTION E-MAILED

08/08/2018

CNRT

NON-FINAL ACTION WRITTEN

08/08/2018

DOCK

ASSIGNED TO EXAMINER

03/08/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/04/2018

NWAP

NEW APPLICATION ENTERED

19/04/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ADAPTIVE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.